Physician profile
John P Getsos
NPI 1104049030
$3,054.94
in general payments reported to CMS, 2019-2025
18 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $318 · 2021: $493 · 2022: $312 · 2023: $787 · 2024: $626 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $403.92 | 2019-2025 | |
| Novo Nordisk INC | $346.48 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $327.08 | 2021-2024 | |
| Idorsia Pharmaceuticals US INC | $308.52 | 2022-2024 | Quviviq |
| Bausch Health US, LLC | $285.25 | 2019-2024 | Wellbutrin, Aplenzin |
| Lilly USA, LLC | $260.20 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $259.46 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $216.74 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $171.13 | 2019-2021 | |
| Allergan, INC. | $128.53 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $107.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $58.31 | 2019-2020 | |
| Astellas Pharma US INC | $48.64 | 2019 | |
| Exact Sciences Corporation | $44.23 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $26.01 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $24.48 | 2022 | |
| Amgen INC. | $23.34 | 2019 | |
| Amarin Pharma, INC. | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Getsos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.